Skip to content

To compare the efficacy of Hridhya Mahakashay and Navak Guggulu in the Management of Dyslipidemia

A Clinico Comparative Study on the Efficacy of Hridhya Mahakashay and Navak Guggulu in the Management of Dyslipidemia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059672
Enrollment
60
Registered
2023-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Dr Gadhavi Pratixaben Pratapdan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having age between 18 and 65 years.2.The patient having one or more abnormality in lipid levels.

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and above 65 years 2.Patient having very high level of dyslipidemia. 3.Associated with any other serious systemic disease or complication, which leads to fatal conditions. 4.Type 1 Diabetes Mellitus, Cancer, Pregnant,Systemic disorders, Bleeding disorder, Any serious trauma.

Design outcomes

Primary

MeasureTime frame
Primary:-Results will be assesed on the basis of Lipid Profile Reports.Timepoint: 8 weeks

Secondary

MeasureTime frame
Secondary- Results will be assessed on the basis of improvement in sign & symptoms of Medoroga & AjirnaTimepoint: 4 weeks & 8 weeks

Countries

India

Contacts

Public ContactDr Ranjan Kr Kalita

Govt Ayurvedic College and Hospital Ghy 14

rkslavia1972@gmail.com8011566721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026